A V Espinosa1, L Porchia, M D Ringel
1Divisions of Endocrinology and Oncology, Department of Medicine, The Ohio State University College of Medicine and Arthur G. James Comprehensive Cancer Center, Columbus, OH, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Activating BRAF mutations drive papillary thyroid cancer. Targeting BRAF offers a promising therapeutic strategy for aggressive thyroid cancers unresponsive to standard treatments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: